Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 2

Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography

Pages
137–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

STE may be useful in detecting preclinical LV impairment in patients with NASH. (Anatolian J Cardiol 2015; 15: 137-42)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Nonalcoholic steatohepatitis (NASH) is a part of histological spectrum of nonalcoholic fatty liver disease (NAFLD).
📊
Key Findings & Data:Methods: Twenty-eight biopsy-proven NASH patients (mean age 41.6±9.8, 16 male) without hypertension and diabetes mellitus were included in study.
💡
Conclusion & Impact:STE may be useful in detecting preclinical LV impairment in patients with NASH. (Anatolian J Cardiol 2015; 15: 137-42)
🔬Design:Modeling & Simulation
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Nonalcoholic steatohepatitis (NASH) is a part of histological spectrum of nonalcoholic fatty liver disease (NAFLD). Higher incidence of cardiovascular mortality has been reported in studies including patients with NAFLD. Impaired myocardial function can be detected by a novel echocardiographic method called speckle tracking echocardiography (STE) when conventional methods were normal. Methods: Twenty-eight biopsy-proven NASH patients (mean age 41.6±9.8, 16 male) without hypertension and diabetes mellitus were included in study. All patients underwent transthoracic echocardiography. Offline analyses of images was performed and strain (S), strain rate (SR) parameters compared between NASH patients and controls. Statistical analysis were done by independent samples t test between groups and a multiple linear regression model was used to identify the statistical significance of relationships between selected variables. Results: RSR-S values were similar but RS, RSR-E, RSR-E/A values were significantly lower and RSR-A was higher in the NASH patients. There were no significant differences in CS, CSR-S, CSR-E, CSR-A and CSR-E/A values among the two groups. The most impressive results were obtained from longitudinal strain and strain rate parameters. LS, LSR-S, LSR-E, LSR-A, values were significantly lower in NASH group when compared with healty controls. Linear regression analysis showed that RS and LS was not associated with diastolic blood pressure, total cholesterol and LDL cholesterol. Conclusion: The LV longitudinal and radial systolic functions may be deteriorated in patients with NASH even in the absence of apparent decrease in the LV ejection fraction. STE may be useful in detecting preclinical LV impairment in patients with NASH. (Anatolian J Cardiol 2015; 15: 137-42)

🔖

Cite This Article

BAKTIR, A. O., ŞARLI, B., ALTEKİN, R. E., KARAMAN, A., ARINÇ, H., SAĞLAM, H., DOĞAN, Y., ERDEN, A., KARAMAN, H. (2015). Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 2, 137–142. https://ajindex.com/articles/365943

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology 2007
  2. [CrossRef] 2. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006
  3. [CrossRef] 3. Alper AT, Hasdemir H, Şahin S, Ontürk E, Akyol A, Nurkalem Z, et al. The relationship between nonalcoholic fatty liver disease an d the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2008
  4. Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006
  5. [CrossRef] 5. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2006
  6. [CrossRef] 6. Sert A, Aypar E, Pirgon O, Yılmaz H, Odabaş D, Tolu I. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol 2013
  7. [CrossRef] 7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005
  8. [CrossRef] 8. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002
  9. [CrossRef] 9. Altekin RE, Yanıkoğlu A, Baktır AO, Karakaş MS, Özel D, Çilli A, et al. Assessment of subclinical left ventricular dysfunction in obstructive sleep apnea patients with speckle tracking echocardiography. Int J Cardiova